1. The development of the RTS,S malaria vaccine candidate: challenges and lessons;Ballou;Parasite Immunol,2009
2. Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites;The RTS SCTP;PloS Med,2014
3. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomized, controlled trial;The RTS SCTP;Lancet,2015
4. Questions and answers on malaria vaccines;Immunization VaB, WHO,2014
5. The public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using Phase III data and simulation models;Penny;BMC Med,2015